Werewolf Therapeutics, Inc. (HOWL)
NASDAQ·Healthcare·Biotechnology
$0.98
-0.62%
Mkt Cap $46.90M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$6.50
Range $1.00 – $12.00
Implied Upside
+566.0%
Consensus $6.50 vs current $0.98
NASDAQ·Healthcare·Biotechnology
$0.98
-0.62%
Mkt Cap $46.90M
No recent rating data.
Price Target (2 analysts)
$6.50
Range $1.00 – $12.00
+566.0%
Consensus $6.50 vs current $0.98